Skip to main content
. 2014 Dec 1;7(12):8453–8461.

Figure 1.

Figure 1

Inhibitory effects of formononetin on NSCLC cell proliferation. Lung cancer cells were treated with different concentrations of formononetin (50, 100, 150 and 200 μM) for 12 h, 24 h and 48 h. MTT assay was performed to determine the proliferation of A549 (A), NCI-H23 (B) and 16HBE-T cells (C).